In 2023, actual hospital discharges for adnexa and eye diseases in Canada stood at 6.5 thousand. The forecast for 2024 shows discharges reaching 6.79 thousand, indicating a growth trend. The forecasted year-on-year growth rates from 2024 to 2028 are consistent, with a noticeable annual increase reflecting an upward trajectory. The Compound Annual Growth Rate (CAGR) from 2024 to 2028 is anticipated to be approximately 4.4%, demonstrating a steady rise in hospital discharges for adnexa and eye diseases over this period.
Future trends to watch for include:
- The impact of technological advancements in medical treatments and diagnostics, which may influence discharge rates.
- Policy changes in healthcare delivery that could affect hospital capacity and discharge processes.
- Shifts in demographic trends, particularly aging populations, which might drive an increase in cases.
